Synthesis of penaresidin derivatives and its biological activity

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 14, 2007, Pages 4910-4916

  Ohshita, Kengo ^a   Ishiyama, Haruaki ^a   Takahashi, Yohei ^a   Ito, Junji ^b   Mikami, Yuzuru ^b   Kobayashi, Jun'ichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Antimicrobial activity; Azetidine ring; Cytotoxicity; Penaresidin derivatives

Indexed keywords

ANTIINFECTIVE AGENT; PENARESIDIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANCER CELL CULTURE; CANDIDA ALBICANS; CELL STRAIN HT29; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LUNG CANCER; MICROCOCCUS LUTEUS; STAPHYLOCOCCUS AUREUS; STEREOISOMERISM;

ALKANES; ANTI-BACTERIAL AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; ISOMERISM; MOLECULAR STRUCTURE; ORGANIC CHEMICALS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34249690092     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.04.049     Document Type: Article

References (19)

1. Kobayashi J., Ishibashi M., Walchli M.R., Yamamura S., and Ohizumi Y. Heterocycles 42 (1996) 943-970
2. Kobayashi J., Cheng J., Ishibashi M., Walchli M.R., Yamamura S., and Ohizumi Y. J. Chem. Soc., Perkin Trans. 1 (1991) 1135-1137
3. Kobayashi J., Tsuda M., Chen J.-F., Ishibashi M., Takikawa H., and Mori K. Tetrahedron Lett. 37 (1996) 6775-6776
4. For previous synthesis of azetidine alkaloids and analogues, see:. Hiraki T., Yamagiwa Y., and Kamikawa T. Tetrahedron Lett. 36 (1995) 4841-4844
5. Takikawa H., Maeda T., and Mori K. Tetrahedron Lett. 36 (1995) 7689-7692
6. Yoda H., Oguchi T., and Takabe K. Tetrahedron: Asymmetry 7 (1996) 2113-2116
7. Yashima A., Takikawa H., and Mori K. Liebigs Ann. 7 (1996) 1083-1089
8. Mori K. J. Heterocyclic Chem. 33 (1996) 1497-1517
9. Yoda H., Oguchi T., and Takabe K. Tetrahedron Lett. 38 (1997) 3283-3284
10. Knapp S., and Dong Y. Tetrahedron Lett. 38 (1997) 3813-3816
11. Takikawa H., Maeda T., and Seki M. J. Chem. Soc., Perkin Trans. 1 (1997) 97-111
12. Lin G.Q., and Liu D.G. Heterocycles 47 (1998) 337-348
13. Liu D.G., and Lin G.Q. Tetrahedron Lett. 40 (1999) 337-348
14. Salgado A., Boeykens M., Gauthier C., Declercq J., and De Kimpe N. Tetrahedron 58 (2002) 2763-2775
15. Yoda H., Uemura T., and Takabe K. Tetrahedron Lett. 44 (2003) 977-979
16. Salgado A., Boeykens M., Gauthier C., Dejaegher Y., Verniest G., Lopin C., Tehrani K.A., and De Kimpe N. Tetrahedron 59 (2003) 2231-2239
17. Burtoloso A.C.B., and Correia C.R.D. Tetrahedron Lett. 45 (2004) 3355-3358
18. Compound 10 was prepared from N-(tert-butoxycarbonyl)-d-serine methyl ester (from Aldrich, 97%) according to the following reference. Garner P., Park J.M., and Malicki E. J. Org. Chem. 53 (1988) 4395-4398
19. Murakami T., Furusawa K., Tamai T., Yoshikai K., and Nishikawa M. Bioorg. Med. Chem. Lett. 15 (2005) 1115-1119